Group Overview

This year we celebrate our 20th anniversary as a JSE-listed company. Established from humble beginnings in Durban South Africa, and with a 160 year heritage, we have grown into a leading specialty and branded multinational pharmaceutical company. Our extensive basket of high quality, affordable products treat a broad spectrum of acute and chronic conditions experienced through all stages of life.

Our core categories that received our highest focus during the 2018 financial year included Regional Brands, Anaesthetics, Thrombosis, High Potency & Cytotoxics and Nutritionals.

Our manufacturing capabilities are scaleable to demand and cover a wide variety of product types including injectables, oral solid dose, liquids, semi-solids, steriles, biologicals and active pharmaceutical ingredients. We operate 23* manufacturing facilities across 15* sites and we hold international manufacturing approvals from some of the most stringent global regulatory agencies listed here including, among others, the United States Food and Drug Administration, the Australian Therapeutic Goods Administration and the European Directorate for the Quality of Medicines.

* Since the divestment of our Nutritional's Business to the Lactalis Group on 31 May 2019.

Click here to download our corporate presentation.